Where’s Lilly’s Alzheimer’s approval?

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, global health, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hello, everyone. Damian here. I’d like to heartily recommend you check out Part 1 of The War on Recovery, a yearlong STAT investigation into how the U.S. denies lifesaving medications to people with opioid addiction.

Read the rest…

Read Original Article: Where’s Lilly’s Alzheimer’s approval? »

About The Author